ACORDA THERAPEUTICS, INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.7 USD | -6.67% |
|
0.00% | -95.36% |
| 05-14 | Acorda Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 04-15 | Acorda Therapeutics Delisted from Nasdaq, Now Trading on OTC Pink Market | MT |
Quotes 5-day view
End-of-day quote OTC Markets| 2024-05-20 | 2024-05-21 | 2024-05-22 | 2024-05-23 | 2024-05-24 | |
|---|---|---|---|---|---|
| Last | 0.7 $ | 0.85 $ | 0.72 $ | 0.75 $ | 0.7 $ |
| Volume | 16 122 | 29 363 | 11 021 | 3 973 | 41 081 |
| Change | +∞% | +21.43% | -15.29% | +4.17% | -6.67% |
| Opening | 0.59 | 0.65 | 0.75 | 0.73 | 0.75 |
| High | 0.75 | 0.97 | 0.78 | 0.75 | 0.78 |
| Low | 0.59 | 0.65 | 0.65 | 0.72 | 0.65 |
Performance
| 1 day | -6.67% | ||
| 1 month | -4.11% | ||
| 3 months | -94.78% | ||
| 6 months | -93.30% | ||
| Current year | -95.36% | ||
| 1 year | -94.11% | ||
| 3 years | -99.08% | ||
| 5 years | -99.94% | ||
| 10 years | -99.98% |
Volumes
marketsDaily volume
41 081
Avg. Volume 20 sessions
16 761
Avg. Volume 20 sessions USD
11 732.70
Record volume 1
6 521 070
Record volume 2
3 737 069
Record volume 3
2 676 708
Capital turnover ratio
0.01
Float rotation
0.01
Basic data
Capitalization (USD)
869 468
Net sales (USD)
117 633 000
Number of employees
102
Sales / Employee (USD)
1 153 265
Free-Float
99.33 %
Free-Float capitalization (USD)
863 857
Average Daily Capital Traded
1.35%
Highs and lows
1 week
0.65
0.78
1 month
0.300.97
Current year
0.2518.00
1 year
0.2518.21
3 years
0.25127.20
5 years
0.251 176.00
10 years
0.255 454.00
Indicators
Moving average 5 days
0.74
Moving average 20 days
0.70
Moving average 50 days
3.39
Moving average 100 days
9.15
Price spread / (MMA5)
+5.71%
Price spread / (MMA20)
0.00%
Price spread / (MMA50)
+384.29%
Price spread / (MMA100)
+1,207.14%
STIM
RSI 9 days
44.69
RSI 14 days
34.84
Sector Comparison - Bio Therapeutic Drugs
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| -6.67% | 0.00% | -95.36% | -94.11% | 869K | ||
| -2.20% | +1.18% | +9.91% | +37.47% | 118B | ||
| -1.73% | -2.63% | +10.19% | +32.83% | 106B | ||
| -4.03% | +1.28% | -11.64% | -10.64% | 23.4B | ||
| -1.40% | +2.40% | -1.69% | -10.04% | 22.1B | ||
| -1.05% | -3.37% | -10.23% | -29.55% | 18.34B | ||
| -0.38% | -5.46% | -41.92% | -35.99% | 16.59B | ||
| -0.26% | -9.01% | -15.55% | -33.28% | 15.97B | ||
| +0.62% | -0.21% | +6.45% | +55.65% | 14.03B | ||
| -9.36% | -14.23% | +14.84% | -11.28% | 11.67B | ||
| -0.98% | -4.31% | -31.68% | -35.85% | 7.55B | ||
| -0.87% | -2.09% | -3.55% | +25.68% | 7.53B | ||
| -0.39% | -6.64% | +9.49% | +40.96% | 7.48B | ||
| -2.93% | +3.02% | +0.49% | +47.55% | 7.48B | ||
| +2.46% | +0.67% | +247.45% | +213.28% | 6.92B | ||
| -1.01% | -16.38% | -60.34% | -72.67% | 6.31B | ||
| Average | -1.89% | -3.00% | +1.68% | +7.50% | ||
| Weighted average by Cap. | -1.87% | -0.24% | +5.68% | +20.58% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Monthly variations
Annual change
| 2024 | -95.36% | ||
| 2023 | -1.59% | ||
| 2022 | -67.92% | ||
| 2021 | -42.28% | ||
| 2020 | -66.17% | ||
| 2019 | -86.91% | ||
| 2018 | -27.37% | ||
| 2017 | +14.10% | ||
| 2016 | -56.05% | ||
| 2015 | +4.67% | ||
| 2014 | +39.97% | ||
| 2013 | +17.46% | ||
| 2012 | +4.28% | ||
| 2011 | -12.55% | ||
| 2010 | +8.17% | ||
| 2009 | +22.87% | ||
| 2008 | -6.60% | ||
| 2007 | +38.64% | ||
| 2006 | +135.71% |
- Stock Market
- Equities
- ACOR.Q Stock
- Quotes Acorda Therapeutics, Inc.
